IL57297A - 4-amino-2-piperidinoquinazoline derivatives,their preparation and pharmaceutical compositions containing them - Google Patents

4-amino-2-piperidinoquinazoline derivatives,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL57297A
IL57297A IL57297A IL5729779A IL57297A IL 57297 A IL57297 A IL 57297A IL 57297 A IL57297 A IL 57297A IL 5729779 A IL5729779 A IL 5729779A IL 57297 A IL57297 A IL 57297A
Authority
IL
Israel
Prior art keywords
piperidinoquinazoline
derivatives
amino
preparation
pharmaceutical compositions
Prior art date
Application number
IL57297A
Other languages
English (en)
Other versions
IL57297A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL57297A0 publication Critical patent/IL57297A0/xx
Publication of IL57297A publication Critical patent/IL57297A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL57297A 1978-05-18 1979-05-16 4-amino-2-piperidinoquinazoline derivatives,their preparation and pharmaceutical compositions containing them IL57297A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2035178 1978-05-18

Publications (2)

Publication Number Publication Date
IL57297A0 IL57297A0 (en) 1979-09-30
IL57297A true IL57297A (en) 1983-02-23

Family

ID=10144517

Family Applications (1)

Application Number Title Priority Date Filing Date
IL57297A IL57297A (en) 1978-05-18 1979-05-16 4-amino-2-piperidinoquinazoline derivatives,their preparation and pharmaceutical compositions containing them

Country Status (30)

Country Link
US (1) US4243666A (hu)
JP (1) JPS554370A (hu)
AR (2) AR223487A1 (hu)
AT (1) ATA363379A (hu)
AU (1) AU512947B2 (hu)
BE (1) BE876297A (hu)
CA (1) CA1240325A (hu)
CH (1) CH643553A5 (hu)
CS (1) CS214796B2 (hu)
DD (1) DD143613A5 (hu)
DE (1) DE2919800A1 (hu)
DK (1) DK159079A (hu)
ES (2) ES480671A1 (hu)
FI (1) FI64589C (hu)
FR (1) FR2434162A1 (hu)
GR (1) GR72824B (hu)
HU (1) HU182562B (hu)
IL (1) IL57297A (hu)
IN (1) IN153045B (hu)
IT (1) IT1114222B (hu)
LU (1) LU81284A1 (hu)
NL (1) NL172157C (hu)
NO (1) NO791648L (hu)
NZ (1) NZ190465A (hu)
PH (1) PH14802A (hu)
PL (2) PL121158B1 (hu)
PT (1) PT69622A (hu)
SE (1) SE439306B (hu)
YU (2) YU115279A (hu)
ZA (1) ZA792390B (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4607034A (en) * 1979-10-29 1986-08-19 Mitsubishi Yuka Pharmaceutical Co., Ltd. Quinazoline derivatives and pharmaceutical composition thereof
JPS5962766U (ja) * 1982-06-30 1984-04-25 守田 智 小動物用給水器
GB8414518D0 (en) * 1984-06-07 1984-07-11 Pfizer Ltd Therapeutic agents
US5801195A (en) * 1994-12-30 1998-09-01 Celgene Corporation Immunotherapeutic aryl amides
US6248888B1 (en) 1997-11-14 2001-06-19 Teva Pharmaceutical Industries Ltd. Process for the preparation of terazosin hydrochloride dihydrate
KR20030069218A (ko) * 2001-01-18 2003-08-25 다케다 야쿠힌 고교 가부시키가이샤 벤질피페리딘 화합물의 제조 방법
US6746460B2 (en) * 2002-08-07 2004-06-08 Satiety, Inc. Intra-gastric fastening devices
WO2005042501A1 (en) * 2003-11-03 2005-05-12 Warner-Lambert Company Llc Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
AR063275A1 (es) * 2006-10-12 2009-01-14 Epix Delaware Inc Compuestos de carboxamida, una composicion farmaceutica que los comprende y su uso en la preparacion de un medicamento para el tratamiento de enfermedades mediadas por la activacion de ccr2.
KR20140069232A (ko) * 2007-04-04 2014-06-09 시플라 리미티드 에르로티닙 및 그의 약학적으로 허용가능한 염의 제조방법
KR20100102646A (ko) * 2007-12-11 2010-09-24 가부시키가이샤 사이토파스파인더 카르복스아미드 화합물 및 케모카인 수용체 길항제로서의 이의 용도
MX2011004295A (es) * 2008-11-14 2011-05-23 Hoffmann La Roche Derivados de quinazolina como antagonistas del receptor de neurocinina 3 (nk3).

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1156973A (en) * 1965-07-06 1969-07-02 Quinazoline Derivatives
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
FR2321890A1 (fr) * 1975-08-26 1977-03-25 Synthelabo Nouveaux derives de la quinazoline, leurs sels, leur preparation et les medicaments qui en renferment
DK140695C (da) * 1976-05-07 1980-05-12 Synthelabo Analogifremgangsmaade til fremstilling af 2,4-diamino-6,7-dimethoxyquinazolinderivater eller syreadditionssalte heraf

Also Published As

Publication number Publication date
US4243666A (en) 1981-01-06
DK159079A (da) 1979-11-19
BE876297A (fr) 1979-11-16
AU4710179A (en) 1979-11-22
DE2919800A1 (de) 1979-11-22
NL172157C (nl) 1983-07-18
SE7904358L (sv) 1979-11-19
FI791562A (fi) 1979-11-19
IT1114222B (it) 1986-01-27
SE439306B (sv) 1985-06-10
AR223487A1 (es) 1981-08-31
CH643553A5 (de) 1984-06-15
JPS554370A (en) 1980-01-12
PT69622A (en) 1979-06-01
NO791648L (no) 1979-11-20
ATA363379A (de) 1983-05-15
HU182562B (en) 1984-02-28
YU115279A (en) 1983-04-30
YU256382A (en) 1983-04-30
ZA792390B (en) 1980-07-30
NZ190465A (en) 1981-05-01
FI64589C (fi) 1983-12-12
AU512947B2 (en) 1980-11-06
DD143613A5 (de) 1980-09-03
IL57297A0 (en) 1979-09-30
ES8101584A1 (es) 1980-12-16
GR72824B (hu) 1983-12-06
PH14802A (en) 1981-12-14
CA1240325A (en) 1988-08-09
FI64589B (fi) 1983-08-31
PL215626A1 (hu) 1980-08-25
ES480671A1 (es) 1980-08-16
AR224784A1 (es) 1982-01-15
NL7903853A (nl) 1979-11-20
IN153045B (hu) 1984-05-26
PL223844A1 (hu) 1981-01-02
IT7922720A0 (it) 1979-05-16
FR2434162A1 (fr) 1980-03-21
NL172157B (nl) 1983-02-16
ES488210A0 (es) 1980-12-16
LU81284A1 (fr) 1980-12-16
FR2434162B1 (hu) 1983-04-22
PL121158B1 (en) 1982-04-30
PL120651B1 (en) 1982-03-31
JPS5623992B2 (hu) 1981-06-03
CS214796B2 (en) 1982-05-28

Similar Documents

Publication Publication Date Title
IL56992A (en) N-heterocyclyl-4-piperidinamines,their preparation and pharmaceutical compositions containing them
IL57708A0 (en) Aminopropoxyindole derivatives,their preparation and pharmaceutical compositions containing them
IL60129A0 (en) Phenylsulphonamide derivatives,their preparation and pharmaceutical compositions containing them
DE3068678D1 (en) 3-aminopropoxyaryl derivatives, their preparation and pharmaceutical compositions containing them
IL57297A0 (en) 4-amino-2-piperidinoquinazoline derivatives,their preparation and pharmaceutical compositions containing them
DE2965287D1 (en) Bis-imidazoles, their preparation and pharmaceutical compositions containing them
IL56856A (en) 4,5-diaryl-pyrrole derivatives,their preparation and pharmaceutical compositions containing them
IL60359A (en) Dialkylaminoalkoxyiminocycloalkane derivatives,their preparation and pharmaceutical compositions containing them
IL60058A0 (en) Hydroxyamino-eburnane derivatives,their preparation and pharmaceutical compositions containing them
IL56816A0 (en) N-phenylaniline derivatives,their preparation and pharmaceutical compositions containing them
IL58620A (en) Aryltrifluoroethanol derivatives,their preparation and pharmaceutical compositions containing them
IL57891A0 (en) Alkylthiophenoxyalkylamines,their preparation and pharmaceutical compositions containing them
IL56686A0 (en) Acylaminoalkyl-syanoguanidines,their preparation and pharmaceutical compositions containing them
IL56890A0 (en) 2-amino-carbazole derivatives,their preparation and pharmaceutical compositions containing them
IL56913A (en) Sprio-steroid-oxazolidinone derivatives,their preparation and pharmaceutical compositions containing them
IL57219A (en) 10-methoxy-daunorubicin,10-methoxy-doxorubicin,their derivatives,preparation thereof,and pharmaceutical compositions comprising them
IL57754A0 (en) Benzopyranotriazoles,their preparation and pharmaceutical compositions containing them
IL60927A (en) Amino-propanoloxytetrahydroquinoline derivatives,their preparation and pharmaceutical compositions containing them
DE2963868D1 (en) Carbostyrile derivatives, their preparation and pharmaceutical compositions containing them
IL56075A0 (en) Novel arylaminoimidazoline derivatives,their preparation and pharmaceutical compositions containing them
IL56728A (en) Androstadienes,their preparation and pharmaceutical compositions containing them
IL60548A0 (en) Ergol-8-ene and ergolin derivatives,their preparation and pharmaceutical compositions containing them
ZA7930B (en) 3-aminopropoxyaryl derivatives,their preparation and pharmaceutical compositions containing them
GB2024818B (en) Phenathrenederivatives, their preparation and pharmaceutical compositions containing them
IL56962A (en) Substituted n-iminomethyl-piperidines,their preparation and pharmaceutical compositions containing them